Zitvogel L - Search Results

1

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity.

Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM, Deleo AB, et al. Mayordomo JI, et al. Among authors: zitvogel l. Nat Med. 1995 Dec;1(12):1297-302. doi: 10.1038/nm1295-1297. Nat Med. 1995. PMID: 7489412

2

Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.

Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT. Zitvogel L, et al. J Immunol. 1995 Aug 1;155(3):1393-403. J Immunol. 1995. PMID: 7636204

3

Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.

Zitvogel L, Tahara H, Cai Q, Storkus WJ, Muller G, Wolf SF, Gately M, Robbins PD, Lotze MT. Zitvogel L, et al. Hum Gene Ther. 1994 Dec;5(12):1493-506. doi: 10.1089/hum.1994.5.12-1493. Hum Gene Ther. 1994. PMID: 7711142

4

Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

Tahara H, Zitvogel L, Storkus WJ, Zeh HJ 3rd, McKinney TG, Schreiber RD, Gubler U, Robbins PD, Lotze MT. Tahara H, et al. Among authors: zitvogel l. J Immunol. 1995 Jun 15;154(12):6466-74. J Immunol. 1995. PMID: 7759882

5

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ. Zitvogel L, et al. J Exp Med. 1996 Jan 1;183(1):87-97. doi: 10.1084/jem.183.1.87. J Exp Med. 1996. PMID: 8551248 Free PMC article.

6

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

Zitvogel L, Robbins PD, Storkus WJ, Clarke MR, Maeurer MJ, Campbell RL, Davis CG, Tahara H, Schreiber RD, Lotze MT. Zitvogel L, et al. Eur J Immunol. 1996 Jun;26(6):1335-41. doi: 10.1002/eji.1830260624. Eur J Immunol. 1996. PMID: 8647214

7

IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts.

Tahara H, Lotze MT, Robbins PD, Storkus WJ, Zitvogel L. Tahara H, et al. Among authors: zitvogel l. Hum Gene Ther. 1995 Dec;6(12):1607-24. doi: 10.1089/hum.1995.6.12-1607. Hum Gene Ther. 1995. PMID: 8664385 No abstract available.

8

Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

Maeurer MJ, Martin D, Walter W, Liu K, Zitvogel L, Halusczcak K, Rabinowich H, Duquesnoy R, Storkus W, Lotze MT. Maeurer MJ, et al. Among authors: zitvogel l. J Exp Med. 1996 Apr 1;183(4):1681-96. doi: 10.1084/jem.183.4.1681. J Exp Med. 1996. PMID: 8666926 Free PMC article.

9

Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA.

Maeurer M, Zitvogel L, Elder E, Storkus WJ, Lotze MT. Maeurer M, et al. Among authors: zitvogel l. Nat Immun. 1995 Apr;14(4):188-97. Nat Immun. 1995. PMID: 8696008

10

Murine models of cancer cytokine gene therapy using interleukin-12.

Tahara H, Zitvogel L, Storkus WJ, Robbins PD, Lotze MT. Tahara H, et al. Among authors: zitvogel l. Ann N Y Acad Sci. 1996 Oct 31;795:275-83. doi: 10.1111/j.1749-6632.1996.tb52677.x. Ann N Y Acad Sci. 1996. PMID: 8958939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters